Significant modifications (increase or minimize) during the plasma levels of the progestin are actually pointed out in some cases of co-administration with non-nucleoside reverse transcriptase inhibitors.Excretion The concentrations of medroxyprogesterone acetate decrease exponentially right until they grow to be undetectable (S. MEC 2).[one] Risk